You can see I have a project on ampd1 and I actually have a facebook group of people with this gene defect, and their issues are much more complex than the muscle phenotype.

After exercise, they are known to get high in adenosine systemically, so how does that elevation interact with regulation of other ATP in other places from muscle?

Particularly, it seems that heterozygotes (thought to be carriers but who produce about half the normal level of the protein) seem to have more issues of impaired regulation than the homozygotes.Why would that happen? This common genetic defect is very underdiagnosed because few people with the genetics for it actually have the recognized phenotype but they do share a lot of other issues.

I would hope that by studying this population, that much more could be learned about regulation of ATP since the gene defect seems to require a double hit before those with this deficiency will acquire the recognized phenotype: muscle soreness and fatigue.

More Susan Costen Owens's questions See All
Similar questions and discussions